Neuroimaging Biomarkers

Alzheimer’s disease Biomarkers, with emphasis on cerebrospinal fluid biomarkers and neuroimaging. Mild Cognitive Impairment (MCI) of Neuroimaging-biomarkers allow an early diagnosis in preclinical stages of Alzheimer’s disease. Biomarker changes in patients with late-onset AD, including findings from studies using structural and functional magnetic resonance imaging (MRI), advanced MRI techniques (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion), positron emission tomography with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers, and CSF protein levels. The dynamic measures of these imaging biomarkers are used to predict the disease progression in the early stages and improve the assessment of therapeutic efficacy in these diseases in future clinical trials.

 

 

  • Neurogenesis & Neuron Regeneration
  • Neuropathology
  • Cerebrospinal fluid biomarker
  • Structural and functional biomarkers

Related Conference of Neuroimaging Biomarkers

December 11-12, 2023

5th World Brain Congress

Rome, Italy
February 01-02, 2024

33rd world congress on Neurology and Therapeutics

Dubai, UAE
February 08-09, 2024

4th Annual Dementia Congress

Paris, France
February 08-09, 2024

5th Global Summit on Brain Disorders and Therapeutics

Madrid, Spain
February 08-09, 2024

6th World Depression Congress

Paris, France
March 14-15, 2024

36th World Conference on Neurology

Paris, France
March 18-19, 2024

28th International Conference on Neurology & Neurophysiology

Zurich, Switzerland
April 11-12, 2024

36th World Congress on Neurorehabilitation

Amsterdam, Netherlands
April 11-12, 2024

38th European Neurology Congress

Amsterdam, Netherlands
April 11-12, 2024

36th World Neuroscience and Neurology Conferences

Amsterdam, Netherlands
May 30-31, 2024

2nd International conference on Neuro Surgery

Vienna, Austria
June 13-14, 2024

37th European Neurology Congress 2024

Rome, Italy
June 27-28, 2024

2nd International conference on Dementia

London, UK
August 13-14, 2024

14th Global Alzheimers Summit

Amsterdam, Netherlands

Neuroimaging Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in